Ledger.Open graph →
SEC Form D · filed October 3, 2023

Biolexis Therapeutics Inc

Offering
$725K
Sold
$725K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
American Fork, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Dr. David J. Bearss · American Fork, UTExec · DirectorDr. Hariprasad J. Vankayalapati · American Fork, UTExec · DirectorDavid O. Taylor · American Fork, UTExec · DirectorDr. David J. Bearss · American Fork, UTExec · DirectorDr. Hariprasad J. Vankayalapati · American Fork, UTExec · DirectorDavid O. Taylor · American Fork, UTExec · DirectorBrad Mcgill · San Juan, Puerto RicoExec · DirectorSteve Aoki · LOS ANGELES, CAExec · DirectorAoki Labs GP I, LLC · LOS ANGELES, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗